COMPANY PROFILE // THE 014 REPORT

Belite Bio, Inc.

BLTE (Nasdaq)

Assembled from 2 government sources in 1.8 s

Built from public records at 2026-11-20 19:39 ET. Every figure links to its source. Flags and checks built 2026-11-19 21:24 ET. Sources

FLAGS · DISCLOSURE · SUMMARY

Missing or hidden

No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).

✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration

No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.

BELITE BIO, INC is an SEC-registered company in pharmaceutical preparations, incorporated in Cayman Islands, based in San Diego, CA; listed as BLTE (Nasdaq).[source] It has filed 79 documents with the SEC in the last 12 months; the latest is Form 424B5, filed 2026-11-17.[source] Its largest institutional holders on 13F filings are Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]

0federal award recipients matched by name in USAspending
0lobbying filings name it as client
79SEC filings in the last 12 months
$1.12Bheld by its 10 largest 13F holders (as of 2026-06-30)
SEC filings by month, 24 months
2024-12: 02025-01: 62025-02: 32025-03: 72025-04: 12025-05: 32025-06: 02025-07: 12025-08: 42025-09: 22025-10: 52025-11: 12025-12: 72026-01: 22026-02: 12026-03: 122026-04: 262026-05: 82026-06: 52026-07: 02026-08: 62026-09: 32026-10: 62026-11: 32024-122026-11
Flags by level
  • red0
  • amber0
  • info0
Largest 13F holders, value as filed
  • Darwin Global Management, Ltd.$456.6M
  • Paradigm Biocapital Advisors LP$189.8M
  • RTW INVESTMENTS, LP$110.2M
  • MILLENNIUM MANAGEMENT LLC$76.2M
  • MAVERICK CAPITAL LTD$61.0M
  • EVENTIDE ASSET MANAGEMENT, LLC$60.2M
  • DEERFIELD MANAGEMENT COMPANY, L.P.$55.0M
  • Holocene Advisors, LP$38.7M

RECORD · WEB

Ask about this entity

Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).

PEOPLE · COUNSEL · LINKS

Leadership, advisers and links

Officers and directors (Forms 3, 4, 5)

As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.

EVERY LIST AND SOURCE · DATED

Checked and clear

26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.

List or sourceResultCheckedWhat matched
OFAC SDN (Treasury)CLEAR2026-11-18
SAM.gov exclusionsCLEAR2026-11-19
HHS-OIG LEIECLEAR2026-11-13
FARA registrants (DOJ)CLEAR2026-11-19
Regulated facility: compliance, penalties and TRI parent (EPA)CLEAR2026-11-18
Hazardous-waste handler facility (EPA RCRAInfo, sample)CLEAR2026-11-18
Consumer complaints about a company (CFPB)CLEAR2026-11-18
Corporate enforcement action (DOJ, SEC, CFTC, EPA)CLEAR2026-11-18
SEC litigation release (respondent)CLEAR2026-11-18
Federal Reserve Board enforcement action (press release, 2022 onward)CLEAR2026-11-18
Enforcement order against a savings association (OCC, OTS archive to 2011)CLEAR2026-11-18
State environmental enforcement actions (Maryland MDE, Connecticut DEEP)CLEAR2026-11-18
Firm sanctioned or debarred by the IDB Group (incl. cross-debarments by WBG, ADB, EBRD, AfDB as listed by the IDB)CLEAR2026-11-18
UK sanctions designation (FCDO UK Sanctions List)CLEAR2026-11-18
US export screening list party (Consolidated Screening List, ITA)CLEAR2026-11-18
FDA recallCLEAR2026-11-18
FDA import alert or listed firm (Red / Yellow / Green list)CLEAR2026-11-18
Consumer product recall or recalling firm (CPSC, full history)CLEAR2026-11-18
Consumer product recall (CPSC)CLEAR2026-11-18
Vehicle recall, defect investigation or manufacturer (NHTSA ODI)CLEAR2026-11-18
Vehicle recall (NHTSA)CLEAR2026-11-18
FinCEN enforcement action (civil money penalty or consent order, 1999 onward)CLEAR2026-11-18
Union representation election (NLRB)CLEAR2026-11-18
NYC summons against an organization, adjudicated at OATH (all city agencies)CLEAR2026-11-18
Data breach notice to a state Attorney GeneralCLEAR2026-11-18
Data breach notice (California Attorney General)CLEAR2026-11-18

EVERY IDENTIFIER · LINKED

ID crosswalk

IdentifierValueRecord
SEC CIK0001889109source
EIN00-0000000source
Business address (SEC)12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130source

Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.

EACH FEEDS WATCH

Dates coming up

PEERS BY SIC CODE

Industry context

SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.

#42 of 568
federal dollars
#40 of 568
lobbying filings
#163 of 568
SEC filings in 12 months
#359 of 568
flags

Peers, each with its 014

  • PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
  • Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
  • ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
  • ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
  • TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
  • NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
  • Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
  • Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
  • SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
  • Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
  • UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
  • Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)

EVERY SOURCE · NEWEST FIRST

One timeline

141 earlier entries
  • 2026-03-02 filing 6-K
  • 2026-01-30 filing S-8
  • 2026-01-27 filing 6-K
  • 2025-12-02 filing 424B5
  • 2025-12-02 filing 6-K
  • 2025-12-01 filing 424B5
  • 2025-12-01 filing 6-K
  • 2025-12-01 filing 6-K
  • 2025-12-01 filing 6-K
  • 2025-11-10 filing 6-K
  • 2025-10-22 filing F-3ASR
  • 2025-10-17 filing 144
  • 2025-10-16 filing 144
  • 2025-10-14 filing 144
  • 2025-10-14 filing 144
  • 2025-09-18 filing 144
  • 2025-09-08 filing 6-K
  • 2025-08-21 filing 144
  • 2025-08-11 filing 6-K
  • 2025-08-08 filing 424B5
  • 2025-08-07 filing 6-K
  • 2025-07-02 filing 6-K
  • 2025-05-21 filing 144
  • 2025-05-21 filing 6-K
  • 2025-05-14 filing 6-K
  • 2025-04-15 filing 6-K
  • 2025-03-28 filing 6-K
  • 2025-03-21 filing S-8
  • 2025-03-19 filing 144
  • 2025-03-18 filing 6-K
  • 2025-03-17 filing 6-K
  • 2025-03-17 filing 6-K
  • 2025-03-17 filing Annual report (20-F)
  • 2025-02-27 filing 6-K
  • 2025-02-07 filing 424B5
  • 2025-02-06 filing 6-K
  • 2025-01-27 filing 424B7
  • 2025-01-27 filing F-3ASR
  • 2025-01-02 filing 144
  • 2025-01-02 filing 144
  • 2024-11-20 filing 144
  • 2024-11-19 filing 144
  • 2024-11-12 filing 6-K
  • 2024-11-04 filing 6-K
  • 2024-10-08 filing 144/A
  • 2024-10-08 filing 144/A
  • 2024-10-03 filing 144
  • 2024-10-03 filing 144
  • 2024-10-01 filing S-8
  • 2024-09-20 filing 144
  • 2024-09-04 filing 144
  • 2024-09-03 filing 6-K
  • 2024-08-16 filing 144
  • 2024-08-14 filing 144
  • 2024-08-14 filing 144
  • 2024-08-14 filing 144
  • 2024-08-09 filing 6-K
  • 2024-06-04 filing 144
  • 2024-05-30 filing 144
  • 2024-05-30 filing 144
  • 2024-05-17 filing 144
  • 2024-05-16 filing 144
  • 2024-05-14 filing 6-K
  • 2024-04-29 filing 424B5
  • 2024-04-26 filing 6-K
  • 2024-03-22 filing 144
  • 2024-03-22 filing 6-K
  • 2024-03-14 filing 144
  • 2024-03-12 filing 6-K
  • 2024-03-12 filing Annual report (20-F)
  • 2024-03-12 filing 6-K
  • 2023-12-28 filing 144
  • 2023-12-28 filing 144
  • 2023-11-28 filing 144
  • 2023-11-16 filing 144
  • 2023-11-16 filing 144
  • 2023-11-14 filing 6-K
  • 2023-11-06 filing 6-K
  • 2023-09-19 filing S-8
  • 2023-08-31 filing 144
  • 2023-08-31 filing 144
  • 2023-08-09 filing 6-K
  • 2023-07-24 filing 6-K
  • 2023-06-16 filing 6-K
  • 2023-06-16 filing 424B5
  • 2023-06-01 filing 424B5
  • 2023-05-31 filing 6-K
  • 2023-05-30 filing EFFECT
  • 2023-05-30 filing 6-K
  • 2023-05-30 filing 424B5
  • 2023-05-25 filing CORRESP
  • 2023-05-25 filing UPLOAD
  • 2023-05-22 filing F-3
  • 2023-05-11 filing 6-K
  • 2023-05-09 filing EFFECT
  • 2023-05-05 filing CORRESP
  • 2023-05-05 filing UPLOAD
  • 2023-05-01 filing F-3
  • 2023-04-25 filing 6-K
  • 2023-04-03 filing 6-K
  • 2023-03-31 filing Annual report (20-F)
  • 2022-12-13 filing 6-K
  • 2022-11-18 filing 6-K
  • 2022-10-03 filing 6-K
  • 2022-09-16 filing 6-K
  • 2022-08-22 filing 6-K
  • 2022-08-11 filing 6-K
  • 2022-07-19 filing 6-K
  • 2022-07-08 filing S-8
  • 2022-05-12 filing 6-K
  • 2022-05-03 filing 6-K
  • 2022-04-29 filing 424B4
  • 2022-04-28 filing EFFECT
  • 2022-04-28 filing EFFECT
  • 2022-04-28 filing SEC STAFF LETTER
  • 2022-04-27 filing F-1/A
  • 2022-04-25 filing FWP
  • 2022-04-25 filing CORRESP
  • 2022-04-25 filing CORRESP
  • 2022-04-25 filing CERT
  • 2022-04-22 filing F-1/A
  • 2022-04-20 filing F-6
  • 2022-04-20 filing 8-A12B
  • 2022-04-20 filing FWP
  • 2022-04-20 filing F-1/A
  • 2022-04-14 filing CORRESP
  • 2022-04-11 filing CORRESP
  • 2022-04-08 filing UPLOAD
  • 2022-04-05 filing SEC STAFF LETTER
  • 2022-04-05 filing CORRESP
  • 2022-04-05 filing F-1
  • 2022-04-01 filing UPLOAD
  • 2022-03-15 filing DRSLTR
  • 2022-03-15 filing DRS/A
  • 2022-02-14 filing SEC STAFF LETTER
  • 2022-02-04 filing UPLOAD
  • 2022-01-21 filing DRSLTR
  • 2022-01-21 filing DRS/A
  • 2021-12-30 filing UPLOAD
  • 2021-12-01 filing DRSLTR
  • 2021-12-01 filing DRS

RENDERED FROM THIS PAGE

Relationship graph

Darwin Global Management, Ltd. · holderParadigm Biocapital Advisors LP · holderRTW INVESTMENTS, LP · holderMILLENNIUM MANAGEMENT LLC · holderMAVERICK CAPITAL LTD · holderChuang Hao-Yuan · officer or directorLin Yu-Hsin · officer or directorMATA NATHAN L. · officer or directorScholl Hendrik Peter · officer or directorBiddle Gary Clark · officer or directorBelite Bio, Inc.

Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.

DATA MOTION // NEWEST FIRST

What changed

Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-21; the colour is also written out in words.

COUNTS FROM THIS PAGE

Relationships at a glance

10largest institutional holders (13F as filed)
0other entities in the GLEIF ownership tree (ID tier)
0awarding federal agencies
0hiring lobbying firms: possible match: matched by name only, not merged
PRICE · FILINGS · POSTS · NEWS

Market & news

Price
NASDAQ:BLTE The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
Open in
Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

Financials
Filed figures: published SEC values, each linked to its filing.
Official posts
Links to posts from the company's and agencies' verified accounts: not connected yet.
News
Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER

1. Identity

1confirmed members (SEC registrant + GLEIF ownership tree)
0legal entities (LEI) in the ownership tree
25dated filings and events

1 possible match held apart, matched by name only, not counted above.

IdentifierValueHow it was resolvedSource
SEC CIK1889109id:sec-anchor: the SEC registrant record of this companySEC EDGAR
Ticker / exchangeBLTE / NasdaqSEC company record: ticker and exchange as listed on the SEC company recordSEC EDGAR
CUSIP07782B104carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001889109SEC EDGAR
AS FILED · EACH WITH ITS DATE AND FILING

2. Filed figures

Key figures (annual filing)

FigureValuePeriod or as ofSourceBasisRetrievedReport
Net income (loss) (fiscal year ended 2025-12-31)-$77,611,0002025-12-3120-F, XBRL NetIncomeLossas filed2026-11-21 00:39 UTCReport an error
Total assets (at 2025-12-31)$780,556,0002025-12-3120-F, XBRL Assetsas filed2026-11-21 00:39 UTCReport an error
Stockholders' equity (at 2025-12-31)$770,486,0002025-12-3120-F, XBRL StockholdersEquityas filed2026-11-21 00:39 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$352,932,0002025-12-3120-F, XBRL CashAndCashEquivalentsAtCarryingValueas filed2026-11-21 00:39 UTCReport an error

Company profile facts (SEC)

FigureValuePeriod or as ofSourceBasisRetrievedReport
SEC entity typeother2026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error
State of incorporationE92026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error
Fiscal year end (MMDD)12312026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error
Business address12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 921302026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error
ExchangesNasdaq2026-11-20SEC EDGAR company profileas filed2026-11-21 00:39 UTCReport an error

Other filed values

FigureValuePeriod or as ofSourceBasisRetrievedReport
Operating cash flow (fiscal year ended 2025-12-31)-$36,988,0002025-12-3120-F, XBRL NetCashProvidedByUsedInOperatingActivitiesas filed2026-11-21 00:39 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$71,0002025-12-3120-F, XBRL PaymentsToAcquirePropertyPlantAndEquipmentas filed2026-11-21 00:39 UTCReport an error
Operating lease liabilities (at 2025-12-31)$429,0002025-12-3120-F, XBRL OperatingLeaseLiabilityas filed2026-11-21 00:39 UTCReport an error

No estimates: every value is as filed and links to the filing it came from.

Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.

NEWEST FIRST · EACH LINKS TO ITS FILING

3. Registration and filing timeline

AS FILED · LARGEST HOLDERS

10. 13F institutional holders

RankHolder (13F filer)Value heldAs ofSourceRetrievedReport
1Darwin Global Management, Ltd.$456,588,2442026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
2Paradigm Biocapital Advisors LP$189,844,5652026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
3RTW INVESTMENTS, LP$110,150,3982026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
4MILLENNIUM MANAGEMENT LLC$76,155,4382026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
5MAVERICK CAPITAL LTD$61,025,9492026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
6EVENTIDE ASSET MANAGEMENT, LLC$60,181,8042026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
7DEERFIELD MANAGEMENT COMPANY, L.P.$55,003,2882026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
8Holocene Advisors, LP$38,655,6242026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
9Logos Global Management LP$38,496,2502026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error
10UBS Group AG$34,644,9312026-06-30SEC 13F filing2026-11-21 00:39 UTCReport an error

13F as filed: the holder's own report of its position value at the quarter end.

POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS

13. Permits and local records

1 state and city record carry this company's exact name, from 1 source. Possible matches only.

ClinicalTrials.gov (1)

possible match: matched by name only, not merged (1)

Possible match based on name, not a shared identifier. Compare the records.

WHAT THIS PAGE READ

Sources

As of 2026-11-21 (record built 2026-11-21T00:39:38Z). Sources used: SEC EDGAR, SEC 13F holdings.

Not checked: FTC enforcement actions; DOJ press releases (beyond FARA and the corporate enforcement set); federal and state court records; UCC filings, liens and bankruptcy dockets; IRS automatic revocation list; state annual-report dates; company formation dates (only where a state registry record states one).

JSON · MCP · API

API and agents

The same profile as JSON: GET /company/1889109.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001889109. Every source URL used is listed in the file.

Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.